SN
Syndax
SNDX·NASDAQNew York NYFounded 2005110 employees
Mid CapbiotechPublicOncologyHematology
Platform: Menin
Market Cap
$2.5B
All Drugs
3
Clinical Trials
6
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (SNDX)
Loading SNDX stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| SND-4562 | SND-4562 | NDA/BLA | 1 | AuroraA | MCL | ||
| SND-5878 | SND-5878 | NDA/BLA | 2 | Menin | SMA | ||
| SND-9531 | SND-9531 | Phase 3 | 3 | TYK2 | MelanomaMigraine |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)